-
1
-
-
33846138032
-
The role of microbes in Crohn's disease
-
Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis 2007; 44: 256-62.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 256-262
-
-
Eckburg, P.B.1
Relman, D.A.2
-
2
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29.
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
3
-
-
38649115342
-
Microbial influences in inflammatory bowel diseases
-
Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
-
(2008)
Gastroenterology
, vol.134
, pp. 577-594
-
-
Sartor, R.B.1
-
4
-
-
0025887076
-
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
-
Rutgeerts P, Goboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771-4.
-
(1991)
Lancet
, vol.338
, pp. 771-774
-
-
Rutgeerts, P.1
Goboes, K.2
Peeters, M.3
-
5
-
-
0031915148
-
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
-
D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-7.
-
(1998)
Gastroenterology
, vol.114
, pp. 262-267
-
-
D'Haens, G.R.1
Geboes, K.2
Peeters, M.3
Baert, F.4
Penninckx, F.5
Rutgeerts, P.6
-
6
-
-
0026688770
-
Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance
-
Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 33: 1071-5.
-
(1992)
Gut
, vol.33
, pp. 1071-1075
-
-
Giaffer, M.H.1
Clark, A.2
Holdsworth, C.D.3
-
7
-
-
0032982463
-
T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans
-
Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde KH. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999; 44: 812-8.
-
(1999)
Gut
, vol.44
, pp. 812-818
-
-
Duchmann, R.1
May, E.2
Heike, M.3
Knolle, P.4
Neurath, M.5
Meyer zum Buschenfelde, K.H.6
-
8
-
-
79953781975
-
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis
-
Khan KJ, Ullman TA, Ford AC et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 661-73.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 661-673
-
-
Khan, K.J.1
Ullman, T.A.2
Ford, A.C.3
-
9
-
-
33747050143
-
The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients
-
Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141-9.
-
(2006)
J Med Microbiol
, vol.55
, pp. 1141-1149
-
-
Bibiloni, R.1
Mangold, M.2
Madsen, K.L.3
Fedorak, R.N.4
Tannock, G.W.5
-
10
-
-
79955554300
-
The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases
-
Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-8.
-
(2011)
Gastroenterology
, vol.140
, pp. 1720-1728
-
-
Chassaing, B.1
Darfeuille-Michaud, A.2
-
11
-
-
35348857386
-
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
-
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104: 13780-5.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 13780-13785
-
-
Frank, D.N.1
St Amand, A.L.2
Feldman, R.A.3
Boedeker, E.C.4
Harpaz, N.5
Pace, N.R.6
-
12
-
-
0031758230
-
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
-
Darfeuille-Michaud A, Neut C, Barnich N et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405-13.
-
(1998)
Gastroenterology
, vol.115
, pp. 1405-1413
-
-
Darfeuille-Michaud, A.1
Neut, C.2
Barnich, N.3
-
13
-
-
22144476548
-
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
-
Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43: 3380-9.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 3380-3389
-
-
Swidsinski, A.1
Weber, J.2
Loening-Baucke, V.3
Hale, L.P.4
Lochs, H.5
-
14
-
-
34047167850
-
Comparative study of the intestinal mucus barrier in normal and inflamed colon
-
Swidsinski A, Loening-Baucke V, Theissig F et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007; 56: 343-50.
-
(2007)
Gut
, vol.56
, pp. 343-350
-
-
Swidsinski, A.1
Loening-Baucke, V.2
Theissig, F.3
-
15
-
-
78149283854
-
Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria
-
Png CW, Linden SK, Gilshenan KS et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105: 2420-8.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 2420-2428
-
-
Png, C.W.1
Linden, S.K.2
Gilshenan, K.S.3
-
16
-
-
77957047689
-
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
-
Biswas A, Liu YJ, Hao L et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A 2010; 107: 14739-44.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 14739-14744
-
-
Biswas, A.1
Liu, Y.J.2
Hao, L.3
-
17
-
-
80052580369
-
Nod2 is essential for temporal development of intestinal microbial communities
-
Rehman A, Sina C, Gavrilova O et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60: 1354-62.
-
(2011)
Gut
, vol.60
, pp. 1354-1362
-
-
Rehman, A.1
Sina, C.2
Gavrilova, O.3
-
18
-
-
32944464648
-
Pathogen recognition and innate immunity
-
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
-
(2006)
Cell
, vol.124
, pp. 783-801
-
-
Akira, S.1
Uematsu, S.2
Takeuchi, O.3
-
19
-
-
34548457793
-
NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease
-
Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007; 13: 135-9.
-
(2007)
J Endotoxin Res
, vol.13
, pp. 135-139
-
-
Peyrin-Biroulet, L.1
Chamaillard, M.2
-
20
-
-
0035978651
-
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
-
Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
-
(2001)
Nature
, vol.411
, pp. 599-603
-
-
Hugot, J.P.1
Chamaillard, M.2
Zouali, H.3
-
21
-
-
0035978533
-
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
-
Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
-
(2001)
Nature
, vol.411
, pp. 603-606
-
-
Ogura, Y.1
Bonen, D.K.2
Inohara, N.3
-
22
-
-
0036202885
-
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
-
Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867-74.
-
(2002)
Gastroenterology
, vol.122
, pp. 867-874
-
-
Cuthbert, A.P.1
Fisher, S.A.2
Mirza, M.M.3
-
23
-
-
0142180157
-
Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2
-
Girardin SE, Travassos LH, Herve M et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 278: 41702-8.
-
(2003)
J Biol Chem
, vol.278
, pp. 41702-41708
-
-
Girardin, S.E.1
Travassos, L.H.2
Herve, M.3
-
24
-
-
0037458665
-
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease
-
Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-12.
-
(2003)
J Biol Chem
, vol.278
, pp. 5509-5512
-
-
Inohara, N.1
Ogura, Y.2
Fontalba, A.3
-
25
-
-
77956289824
-
Toll-like receptors in inflammatory bowel diseases: a decade later
-
Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010; 16: 1583-97.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 1583-1597
-
-
Cario, E.1
-
27
-
-
0034445697
-
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
-
Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7.
-
(2000)
Infect Immun
, vol.68
, pp. 7010-7017
-
-
Cario, E.1
Podolsky, D.K.2
-
28
-
-
6344225825
-
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells
-
Vora P, Youdim A, Thomas LS et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173: 5398-405.
-
(2004)
J Immunol
, vol.173
, pp. 5398-5405
-
-
Vora, P.1
Youdim, A.2
Thomas, L.S.3
-
29
-
-
33644849605
-
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2
-
Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006; 281: 2005-11.
-
(2006)
J Biol Chem
, vol.281
, pp. 2005-2011
-
-
Voss, E.1
Wehkamp, J.2
Wehkamp, K.3
Stange, E.F.4
Schroder, J.M.5
Harder, J.6
-
30
-
-
7244257312
-
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
-
Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658-64.
-
(2004)
Gut
, vol.53
, pp. 1658-1664
-
-
Wehkamp, J.1
Harder, J.2
Weichenthal, M.3
-
32
-
-
77957586284
-
Intestinal epithelial cells in inflammatory bowel diseases
-
Roda G, Sartini A, Zambon E et al. Intestinal epithelial cells in inflammatory bowel diseases. World J Gastroenterol 2010; 16: 4264-71.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 4264-4271
-
-
Roda, G.1
Sartini, A.2
Zambon, E.3
-
33
-
-
0030569343
-
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells
-
Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-22.
-
(1996)
FEBS Lett
, vol.396
, pp. 319-322
-
-
Zhao, C.1
Wang, I.2
Lehrer, R.I.3
-
34
-
-
0037165196
-
Antimicrobial peptides of multicellular organisms
-
Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
-
(2002)
Nature
, vol.415
, pp. 389-395
-
-
Zasloff, M.1
-
35
-
-
1042267410
-
Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
-
Papo N, Shai Y. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 2003; 24: 1693-703.
-
(2003)
Peptides
, vol.24
, pp. 1693-1703
-
-
Papo, N.1
Shai, Y.2
-
36
-
-
0034252293
-
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria
-
Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113-8.
-
(2000)
Nat Immunol
, vol.1
, pp. 113-118
-
-
Ayabe, T.1
Satchell, D.P.2
Wilson, C.L.3
Parks, W.C.4
Selsted, M.E.5
Ouellette, A.J.6
-
37
-
-
1842453218
-
Defensin-mediated innate immunity in the small intestine
-
Ouellette AJ. Defensin-mediated innate immunity in the small intestine. Best Pract Res Clin Gastroenterol 2004; 18: 405-19.
-
(2004)
Best Pract Res Clin Gastroenterol
, vol.18
, pp. 405-419
-
-
Ouellette, A.J.1
-
38
-
-
0033865538
-
Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia
-
Frye M, Bargon J, Lembcke B, Wagner TO, Gropp R. Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest 2000; 30: 695-701.
-
(2000)
Eur J Clin Invest
, vol.30
, pp. 695-701
-
-
Frye, M.1
Bargon, J.2
Lembcke, B.3
Wagner, T.O.4
Gropp, R.5
-
40
-
-
44149126798
-
Secreted enteric antimicrobial activity localises to the mucus surface layer
-
Meyer-Hoffert U, Hornef MW, Henriques-Normark B et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008; 57: 764-71.
-
(2008)
Gut
, vol.57
, pp. 764-771
-
-
Meyer-Hoffert, U.1
Hornef, M.W.2
Henriques-Normark, B.3
-
41
-
-
0028135495
-
Paneth cell differentiation in the developing intestine of normal and transgenic mice
-
Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A 1994; 91: 10335-9.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 10335-10339
-
-
Bry, L.1
Falk, P.2
Huttner, K.3
Ouellette, A.4
Midtvedt, T.5
Gordon, J.I.6
-
42
-
-
29144483937
-
Reduced Paneth cell alpha-defensins in ileal Crohn's disease
-
Wehkamp J, Salzman NH, Porter E et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005; 102: 18129-34.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 18129-18134
-
-
Wehkamp, J.1
Salzman, N.H.2
Porter, E.3
-
43
-
-
0037417311
-
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
-
Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422: 522-6.
-
(2003)
Nature
, vol.422
, pp. 522-526
-
-
Salzman, N.H.1
Ghosh, D.2
Huttner, K.M.3
Paterson, Y.4
Bevins, C.L.5
-
44
-
-
46349102893
-
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
-
Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008; 57: 903-10.
-
(2008)
Gut
, vol.57
, pp. 903-910
-
-
Simms, L.A.1
Doecke, J.D.2
Walsh, M.D.3
Huang, N.4
Fowler, E.V.5
Radford-Smith, G.L.6
-
45
-
-
40449103288
-
Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin
-
Elphick D, Liddell S, Mahida YR. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol 2008; 172: 702-13.
-
(2008)
Am J Pathol
, vol.172
, pp. 702-713
-
-
Elphick, D.1
Liddell, S.2
Mahida, Y.R.3
-
46
-
-
0842308743
-
Paneth cell granule depletion in the human small intestine under infective and nutritional stress
-
Kelly P, Feakins R, Domizio P et al. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 2004; 135: 303-9.
-
(2004)
Clin Exp Immunol
, vol.135
, pp. 303-309
-
-
Kelly, P.1
Feakins, R.2
Domizio, P.3
-
47
-
-
13244292161
-
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
-
Kobayashi KS, Chamaillard M, Ogura Y et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-4.
-
(2005)
Science
, vol.307
, pp. 731-734
-
-
Kobayashi, K.S.1
Chamaillard, M.2
Ogura, Y.3
-
48
-
-
20244364236
-
Wnt signalling induces maturation of Paneth cells in intestinal crypts
-
van Es JH, Jay P, Gregorieff A et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 2005; 7: 381-6.
-
(2005)
Nat Cell Biol
, vol.7
, pp. 381-386
-
-
van Es, J.H.1
Jay, P.2
Gregorieff, A.3
-
49
-
-
37349070287
-
The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4
-
Wehkamp J, Wang G, Kubler I et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179: 3109-18.
-
(2007)
J Immunol
, vol.179
, pp. 3109-3118
-
-
Wehkamp, J.1
Wang, G.2
Kubler, I.3
-
50
-
-
84887212530
-
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease
-
Koslowski MJ, Kubler I, Chamaillard M et al. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS ONE 2009; 4: e4496.
-
(2009)
PLoS ONE
, vol.4
-
-
Koslowski, M.J.1
Kubler, I.2
Chamaillard, M.3
-
51
-
-
80051507729
-
From intestinal stem cells to inflammatory bowel diseases
-
Gersemann M, Stange EF, Wehkamp J. From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol 2003; 17: 3198-203.
-
(2003)
World J Gastroenterol
, vol.17
, pp. 3198-3203
-
-
Gersemann, M.1
Stange, E.F.2
Wehkamp, J.3
-
52
-
-
16844382886
-
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
-
Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2004; 77: 460-5.
-
(2004)
J Leukoc Biol
, vol.77
, pp. 460-465
-
-
Wehkamp, J.1
Schmid, M.2
Fellermann, K.3
Stange, E.F.4
-
54
-
-
0036270399
-
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins
-
Wehkamp J, Schwind B, Herrlinger KR et al. Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci 2002; 47: 1349-55.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 1349-1355
-
-
Wehkamp, J.1
Schwind, B.2
Herrlinger, K.R.3
-
55
-
-
77952683762
-
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
-
Peyrin-Biroulet L, Beisner J, Wang G et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A 2010; 107: 8772-7.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 8772-8777
-
-
Peyrin-Biroulet, L.1
Beisner, J.2
Wang, G.3
-
56
-
-
78751653584
-
Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1
-
Schroeder BO, Wu Z, Nuding S et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011; 469: 419-23.
-
(2011)
Nature
, vol.469
, pp. 419-423
-
-
Schroeder, B.O.1
Wu, Z.2
Nuding, S.3
-
57
-
-
0037234635
-
Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis
-
Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 2003; 131: 90-101.
-
(2003)
Clin Exp Immunol
, vol.131
, pp. 90-101
-
-
Fahlgren, A.1
Hammarstrom, S.2
Danielsson, A.3
Hammarstrom, M.L.4
-
58
-
-
0036318272
-
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease
-
Wehkamp J, Fellermann K, Herrlinger KR et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 745-52.
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, pp. 745-752
-
-
Wehkamp, J.1
Fellermann, K.2
Herrlinger, K.R.3
-
59
-
-
0142026070
-
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis
-
Wehkamp J, Harder J, Weichenthal M et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003; 9: 215-23.
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 215-223
-
-
Wehkamp, J.1
Harder, J.2
Weichenthal, M.3
-
60
-
-
33744493110
-
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
-
Schauber J, Rieger D, Weiler F et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18: 615-21.
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, pp. 615-621
-
-
Schauber, J.1
Rieger, D.2
Weiler, F.3
-
61
-
-
33947654353
-
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease
-
Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol 2007; 81: 907-15.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 907-915
-
-
Schmid, M.1
Fellermann, K.2
Fritz, P.3
Wiedow, O.4
Stange, E.F.5
Wehkamp, J.6
-
62
-
-
34548130847
-
Reduced mucosal antimicrobial activity in Crohn's disease of the colon
-
Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 2007; 56: 1240-7.
-
(2007)
Gut
, vol.56
, pp. 1240-1247
-
-
Nuding, S.1
Fellermann, K.2
Wehkamp, J.3
Stange, E.F.4
-
63
-
-
0042387792
-
Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster
-
Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 2003; 73: 591-600.
-
(2003)
Am J Hum Genet
, vol.73
, pp. 591-600
-
-
Hollox, E.J.1
Armour, J.A.2
Barber, J.C.3
-
64
-
-
33748558056
-
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
-
Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439-48.
-
(2006)
Am J Hum Genet
, vol.79
, pp. 439-448
-
-
Fellermann, K.1
Stange, D.E.2
Schaeffeler, E.3
-
65
-
-
78649479154
-
Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease
-
Aldhous MC, Abu BS, Prescott NJ et al. Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum Mol Genet 2010; 19: 4930-8.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 4930-4938
-
-
Aldhous, M.C.1
Abu, B.S.2
Prescott, N.J.3
-
66
-
-
76349096044
-
Association of higher DEFB4 genomic copy number with Crohn's disease
-
Bentley RW, Pearson J, Gearry RB et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 2010; 105: 354-9.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 354-359
-
-
Bentley, R.W.1
Pearson, J.2
Gearry, R.B.3
-
68
-
-
34249945094
-
Defensins and other antimicrobial peptides in inflammatory bowel disease
-
Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23: 370-8.
-
(2007)
Curr Opin Gastroenterol
, vol.23
, pp. 370-378
-
-
Wehkamp, J.1
Schmid, M.2
Stange, E.F.3
-
70
-
-
0028265506
-
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis
-
Pullan RD, Thomas GA, Rhodes M et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994; 35: 353-9.
-
(1994)
Gut
, vol.35
, pp. 353-359
-
-
Pullan, R.D.1
Thomas, G.A.2
Rhodes, M.3
-
71
-
-
0030875131
-
Colonic mucus and ulcerative colitis
-
Rhodes JM. Colonic mucus and ulcerative colitis. Gut 1997; 40: 807-8.
-
(1997)
Gut
, vol.40
, pp. 807-808
-
-
Rhodes, J.M.1
-
72
-
-
0034994474
-
Microbial modulation of innate defense: goblet cells and the intestinal mucus layer
-
Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001; 73: 1131S-41S.
-
(2001)
Am J Clin Nutr
, vol.73
-
-
Deplancke, B.1
Gaskins, H.R.2
-
73
-
-
0030737814
-
Histochemistry of the surface mucous gel layer of the human colon
-
Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997; 40: 782-9.
-
(1997)
Gut
, vol.40
, pp. 782-789
-
-
Matsuo, K.1
Ota, H.2
Akamatsu, T.3
Sugiyama, A.4
Katsuyama, T.5
-
74
-
-
0036340041
-
The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon
-
Katz JP, Perreault N, Goldstein BG et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002; 129: 2619-28.
-
(2002)
Development
, vol.129
, pp. 2619-2628
-
-
Katz, J.P.1
Perreault, N.2
Goldstein, B.G.3
-
75
-
-
0035824487
-
Requirement of Math1 for secretory cell lineage commitment in the mouse intestine
-
Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155-8.
-
(2001)
Science
, vol.294
, pp. 2155-2158
-
-
Yang, Q.1
Bermingham, N.A.2
Finegold, M.J.3
Zoghbi, H.Y.4
-
76
-
-
60549086579
-
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
-
Gersemann M, Becker S, Kubler I et al. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009; 77: 84-94.
-
(2009)
Differentiation
, vol.77
, pp. 84-94
-
-
Gersemann, M.1
Becker, S.2
Kubler, I.3
-
77
-
-
79956306866
-
Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis
-
Zheng X, Tsuchiya K, Okamoto R et al. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm Bowel Dis 2011; 17: 2251-60.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 2251-2260
-
-
Zheng, X.1
Tsuchiya, K.2
Okamoto, R.3
-
78
-
-
0033057385
-
Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core
-
Hanski C, Born M, Foss HD et al. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. J Pathol 1999; 188: 304-11.
-
(1999)
J Pathol
, vol.188
, pp. 304-311
-
-
Hanski, C.1
Born, M.2
Foss, H.D.3
-
79
-
-
0030590089
-
Quantitative analysis of MUC2 synthesis in ulcerative colitis
-
Tytgat KM, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 1996; 224: 397-405.
-
(1996)
Biochem Biophys Res Commun
, vol.224
, pp. 397-405
-
-
Tytgat, K.M.1
van der Wal, J.W.2
Einerhand, A.W.3
Buller, H.A.4
Dekker, J.5
-
80
-
-
0032985868
-
Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis
-
Van Klinken BJ, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999; 44: 387-93.
-
(1999)
Gut
, vol.44
, pp. 387-393
-
-
Van Klinken, B.J.1
van der Wal, J.W.2
Einerhand, A.W.3
Buller, H.A.4
Dekker, J.5
-
81
-
-
41349088375
-
Risk factors for opportunistic infections in patients with inflammatory bowel disease
-
Toruner M, Loftus Jr EV, Harmsen WS et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-36.
-
(2008)
Gastroenterology
, vol.134
, pp. 929-936
-
-
Toruner, M.1
Loftus Jr., E.V.2
Harmsen, W.S.3
-
82
-
-
38749095183
-
European evidence-based consensus on the management of ulcerative colitis: current management
-
Travis SP, Stange EF, Lemann M et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62.
-
(2008)
J Crohns Colitis
, vol.2
, pp. 24-62
-
-
Travis, S.P.1
Stange, E.F.2
Lemann, M.3
-
83
-
-
34248399194
-
Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin
-
Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 2007; 75: 2399-407.
-
(2007)
Infect Immun
, vol.75
, pp. 2399-2407
-
-
Schlee, M.1
Wehkamp, J.2
Altenhoefer, A.3
Oelschlaeger, T.A.4
Stange, E.F.5
Fellermann, K.6
-
84
-
-
33646884826
-
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
-
Prantera C, Lochs H, Campieri M et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006; 23: 1117-25.
-
(2006)
Aliment Pharmacol Ther
, vol.23
, pp. 1117-1125
-
-
Prantera, C.1
Lochs, H.2
Campieri, M.3
-
85
-
-
0029079279
-
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
-
Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-21.
-
(1995)
Gastroenterology
, vol.108
, pp. 1617-1621
-
-
Rutgeerts, P.1
Hiele, M.2
Geboes, K.3
-
86
-
-
10844224526
-
Trichuris suis therapy in Crohn's disease
-
Summers RW, Elliott DE, Urban Jr. JF, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87-90.
-
(2005)
Gut
, vol.54
, pp. 87-90
-
-
Summers, R.W.1
Elliott, D.E.2
Urban Jr., J.F.3
Thompson, R.4
Weinstock, J.V.5
-
87
-
-
77957886834
-
Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis?
-
Stremmel W, Hanemann A, Ehehalt R, Karner M, Braun A. Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig Dis 2010; 28: 490-6.
-
(2010)
Dig Dis
, vol.28
, pp. 490-496
-
-
Stremmel, W.1
Hanemann, A.2
Ehehalt, R.3
Karner, M.4
Braun, A.5
-
88
-
-
21044457089
-
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
-
Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005; 54: 966-71.
-
(2005)
Gut
, vol.54
, pp. 966-971
-
-
Stremmel, W.1
Merle, U.2
Zahn, A.3
Autschbach, F.4
Hinz, U.5
Ehehalt, R.6
-
89
-
-
38449107095
-
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial
-
Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med 2007; 147: 603-10.
-
(2007)
Ann Intern Med
, vol.147
, pp. 603-610
-
-
Stremmel, W.1
Ehehalt, R.2
Autschbach, F.3
Karner, M.4
-
90
-
-
78649505795
-
Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis - a review of three clinical trials
-
Stremmel W, Hanemann A, Braun A et al. Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis - a review of three clinical trials. Expert Opin Investig Drugs 2010; 19: 1623-30.
-
(2010)
Expert Opin Investig Drugs
, vol.19
, pp. 1623-1630
-
-
Stremmel, W.1
Hanemann, A.2
Braun, A.3
|